Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADMA Biologics

18.89
-1.5100-7.40%
Post-market: 18.890.00000.00%16:43 EDT
Volume:5.97M
Turnover:114.19M
Market Cap:4.51B
PE:22.60
High:20.27
Open:20.00
Low:18.71
Close:20.40
Loading ...
Mar 13, 2020

Major Issues Report

8-K - Current report
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Mar 05, 2020

Major Issues Report

Current report, item 5.02
Feb 24, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 07, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 09, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Jan 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 17, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Nov 19, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 13, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 22, 2019

Major Issues Report

Current report, items 8.01 and 9.01